JanOne Inc.

JAN

US47089W1045

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
3.39 ^USD	-2.87%		-15.46%	+510.81%

May. 17	Exchange-Traded Funds, Equity Futures Tread Water Pre-Bell Friday Amid Waning September Rate Cut Hopes	MT
May. 16	JanOne Closes Acquisition of Blockchain Fintech Firm -- Shares Fall After Hours	MT

Appliance Recycling Centers of America, Inc has Changed its Name to JanOne Inc

September 11, 2019 at 08:03 am EDT

Appliance Recycling Centers of America, Inc changed its name to JanOne Inc.

Latest news about JanOne Inc.

Exchange-Traded Funds, Equity Futures Tread Water Pre-Bell Friday Amid Waning September Rate Cut Hopes	May. 17	MT
JanOne Closes Acquisition of Blockchain Fintech Firm -- Shares Fall After Hours	May. 16	MT
JanOne Inc. completed the acquisition of Alt 5 Sigma Inc.	May. 15	CI
JanOne to Acquire ALT 5 Sigma	May. 10	MT
JanOne Inc. executed a Definitive Agreement to acquire Alt 5 Sigma Inc.	May. 09	CI
JanOne Inc. Reports Earnings Results for the First Quarter Ended March 30, 2024	May. 03	CI
JanOne Files Prospectus for $100 Million Mixed Shelf Offering	Apr. 18	MT
North American Morning Briefing : Stock Futures -2-	Apr. 15	DJ
JanOne Inc. Reports Earnings Results for the Full Year Ended December 30, 2023	Apr. 08	CI
JanOne Inc. announced that it expects to receive $0.6 million in funding	Feb. 22	CI
JanOne Inc. announced that it expects to receive $0.3 million in funding from Live Ventures Incorporated	Feb. 06	CI
JanOne Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Wall Street Set to Open Higher Thursday as Jobless Claims Fall, Ahead of Powell Speech	Nov. 09	MT
Investors Await Jobless Claims Report, Powell Speech as US Futures Remain Flat in Thursday Trading	Nov. 09	MT
Top Premarket Gainers	Nov. 09	MT
JanOne Raises $790,000 in Registered Direct Offering of Shares, Private Placement of Warrants	23-08-23	MT
JanOne Prices Registered Direct Offering, Announces Concurrent Private Placement	23-08-21	MT
JanOne Inc. Reports Earnings Results for the Second Quarter and Six Months Ended July 01, 2023	23-08-15	CI
Janone Inc. Files International Patent Application for Methods of Using Low Dose Naltrexone to Treat Chronic Pain	23-06-28	CI
JanOne Inc. Reports Earnings Results for the First Quarter Ended April 01, 2023	23-05-22	CI
North American Morning Briefing : Debt-Ceiling -2-	23-05-17	DJ
JanOne Says Meeting With US FDA Provided Guidance for Regional Pain Syndrome Drug NDA	23-04-18	MT
JanOne Completes Pre-IND Meeting with FDA on Jan123	23-04-18	CI
JanOne Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-17	CI
JanOne Inc. Auditor Raises 'Going Concern' Doubt	23-04-16	CI

JanOne Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, acquiring, licensing, developing, partnering, and commercializing novel, no-opioid, and non-addictive therapies to address the large, unmet medical need for the treatment of pain and addiction. Its drug candidate, JAN101, is a patented oral, sustained-release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities, such as those with vascular complications of diabetes or Peripheral Artery Disease (PAD) and treats pain. The Companyâs drug candidate is a treatment for Peripheral Artery Disease, a condition that can cause severe pain and affects over 8.5 million people in the United States. The Company operates through the Biotechnology segment, which is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
JANONE INC.	+510.81%	30.7M
IQVIA HOLDINGS INC.	-0.09%	42.12B
LONZA GROUP AG	+49.62%	42.05B
CELLTRION, INC.	-4.96%	29.18B
ICON PUBLIC LIMITED COMPANY	+11.18%	26.02B
ALNYLAM PHARMACEUTICALS, INC.	-21.95%	18.9B
BIO-TECHNE CORPORATION	+8.61%	13.21B
UNITED THERAPEUTICS CORPORATION	+24.73%	12.17B
MEDPACE HOLDINGS, INC.	+28.31%	12.16B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-6.26%	11.42B

Other Biotechnology & Medical Research

JanOne Inc.

Equities

JAN

US47089W1045

Biotechnology & Medical Research

Appliance Recycling Centers of America, Inc has Changed its Name to JanOne Inc

Latest news about JanOne Inc.

Chart JanOne Inc.

Company Profile

Income Statement Evolution

Sector Other Biotechnology & Medical Research